VitaNova Life Sciences (VNOV) Cash & Current Investments (2017 - 2026)
VitaNova Life Sciences (VNOV) posted Cash & Current Investments of $493283.0 for Q1 2026, down 60.83% on a QoQ basis from $1.3 million in Q4 2025, and up 21.75% year-over-year from $405173.0 in Q1 2025.
VitaNova Life Sciences (VNOV) Cash & Current Investments (2017 - 2026) Analysis & Trends
VitaNova Life Sciences' Cash & Current Investments history runs 9 years deep, the most recent figure standing at $493283.0 for Q1 2026.
- Quarterly Cash & Current Investments rose 21.75% year-over-year to $493283.0 in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $493283.0 (up 21.75% YoY) and the FY2025 annual result came in at $301267.0, down 49.2% from the prior year.
- Cash & Current Investments was $493283.0 for Q1 2026 at VitaNova Life Sciences, down from $1.3 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $1.3 million in Q4 2025 and bottomed at $8728.0 in Q2 2023.
- A 5-year average of $361153.3 and a median of $222795.0 in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2023 — Cash & Current Investments sank 70.18% — and 2024, when it soared 7240.02%.
- VitaNova Life Sciences' Cash & Current Investments stood at $36190.0 in 2022, then plunged by 75.88% to $8728.0 in 2023, then surged by 2452.65% to $222795.0 in 2024, then soared by 465.22% to $1.3 million in 2025, then slumped by 60.83% to $493283.0 in 2026.
- Business Quant data shows VNOV's Cash & Current Investments at $493283.0 in Q1 2026, $1.3 million in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 3.98 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 2.18 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 3.94 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 138.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | 200,000.00 |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 79.10 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 336.88 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 15.00 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 493,283.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 2.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 493,283.00 |
| Oct 31, 2025 | 1.26 Mn |
| Jul 31, 2025 | 1.05 Mn |
| Apr 30, 2025 | 301,267.00 |
| Jan 31, 2025 | 405,173.00 |
| Oct 31, 2024 | 222,795.00 |
| Jul 31, 2024 | 141,635.00 |
| Apr 30, 2024 | 593,036.00 |
| Jan 31, 2024 | 808,356.00 |
| Apr 30, 2023 | 8,728.00 |
| Jan 31, 2023 | 11,013.00 |
| Oct 31, 2022 | 36,190.00 |
| Jul 31, 2022 | 29,884.00 |
| Apr 30, 2022 | 23,103.00 |
| Jan 31, 2022 | 36,935.00 |
| Oct 31, 2021 | 31,693.00 |
| Jan 31, 2019 | 50.00 |
| Oct 31, 2018 | 50.00 |
| Jul 31, 2018 | 602.00 |
| Apr 30, 2018 | 4,421.00 |